Global Chemotherapy Infusion Pumps Market Growth 2025-2031

The global Chemotherapy Infusion Pumps market size is predicted to grow from US$ 224 million in 2025 to US$ 337 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.

Chemotherapy pumps are one of the ways patients can have their chemotherapy. It allows patients to have chemo in a controlled way. Chemotherapy pumps are also called infusion pumps. Chemotherapy pumps may be capable of delivering fluids in large or small amounts, and may be used to deliver chemotherapy drugs.

Global Chemotherapy Infusion Pumps key players include Becton, Dickinson, ICU Medical, Terumo, B. Braun, Halyard Health etc. Global top five manufacturers hold a share over 50%. North America is the largest market, with a share over 40%, followed by China and Europe, both have a share over 40% percent.

In terms of product, Syringe Pump is the largest segment, with a share over 30%. And in terms of application, the largest application is Hospital & Clinic, followed by Home Care.

LP Information, Inc. (LPI) ' newest research report, the “Chemotherapy Infusion Pumps Industry Forecast” looks at past sales and reviews total world Chemotherapy Infusion Pumps sales in 2024, providing a comprehensive analysis by region and market sector of projected Chemotherapy Infusion Pumps sales for 2025 through 2031. With Chemotherapy Infusion Pumps sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chemotherapy Infusion Pumps industry.

This Insight Report provides a comprehensive analysis of the global Chemotherapy Infusion Pumps landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chemotherapy Infusion Pumps portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chemotherapy Infusion Pumps market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chemotherapy Infusion Pumps and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chemotherapy Infusion Pumps.

This report presents a comprehensive overview, market shares, and growth opportunities of Chemotherapy Infusion Pumps market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
LVP (Large Volume Pump)
Syringe Pump
Elastomeric Pumps

Segmentation by Application:
Hospital & Clinic
Home Care

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Becton, Dickinson
ICU Medical
Terumo
B. Braun
Halyard Health
Smiths
Baxter International
Fresenius
Moog
Zyno Medical
Micrel Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Chemotherapy Infusion Pumps market?

What factors are driving Chemotherapy Infusion Pumps market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Chemotherapy Infusion Pumps market opportunities vary by end market size?

How does Chemotherapy Infusion Pumps break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.